Member access

4-Traders Homepage  >  Shares  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX   US45822R1014

 SummaryNewsCalendarCompanyFinancialsRevisions 
Company
IntelGenx Technologies Corp. operates as a drug delivery company.It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies.The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
04/01Earnings Release
More about the company
Financials ($)
Sales 2011 6,00 M
EBIT 2011 -0,10 M
Net income 2011 -0,10 M
Debt 2011 -
Yield 2011 -
Sales 2012 0,97 M
EBIT 2012 -1,88 M
Net income 2012 -2,14 M
Debt 2012 -
Yield 2012 -
PER 2011 25,80
PER 2012
Capi. / Sales 2011 5,46x
Capi. / Sales 2012 33,9x
Capitalization 32,7 M
More Financials
Latest news on INTELGENX TECHNOLOGIES COR
12/08 IntelGenx Grants Stock Options
12/02 IntelGenx Grants Extension of Marketing Exclusivity in the U.S. to Edgemont o..
12/02 INTELGENX TECHNOLOGIES : 2014-12-01 IntelGenx and RedHill Biopharma Announce Acc..
11/26 INTELGENX TECHNOLOGIES : 2014-11-26 IntelGenx Announces Update to Settlement of ..
11/26 IIROC Trade Resumption - IntelGenx Corp.
11/26 IntelGenx Announces Update to Settlement of U.S. Patent Litigation Related to..
11/25 INTELGENX TECHNOLOGIES : 2014-11-25 IntelGenx Announces Settlement of U.S. Paten..
11/25 IIROC Trade Halt - IntelGenx Corp.
More news
Sector news
8h ago Roche to pay up to $489 million for next-generation antibody developer
8h ago MERCK : buys Swiss biotech with promising cancer drug
10h ago France fines household product firms 951 million euros for price fixing
More sector news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF